ACE and metabolic syndrome: Posteriorly, their ability to inhibit the enzymatic activities associated with the development of the metabolic syndrome, namely, ACE (antihypertensive), α-glucosidase (antidiabetic), and lipase (antiobesity), was evaluated [11].